Article Text
Statistics from Altmetric.com
Learning objectives
To understand the principles of assessment by type of non-cardiac surgery, the Revised Cardiac Index Risk score, the grade of valve disease and functional capacity.
To understand that adverse events at non-cardiac surgery result from associated coronary disease and the haemodynamic effects of the valve disease.
To understand the precautions necessary during and after non-cardiac surgery and when invasive intervention is indicated in severe aortic stenosis or mitral stenosis.
Introduction
Valve disease is a major concern in patients having non-cardiac surgery. First, it is common (table 1)1–4 particularly in the elderly who may also have other comorbidities. The adult population prevalence of moderate or severe disease is 2.5% and this rises to >13% in people aged ≥75.1 Second, valve disease is often asymptomatic and may be detected for the first time during preoperative assessment for non-cardiac surgery. In the OxVALVE community study,3 moderate or severe valve disease was known in 4.9% people aged >65 and was newly detected by screening in a further 6.4%. Third, valve disease, particularly aortic stenosis (AS), may be associated with coronary disease which contributes to the perioperative risk.5 Fourth, recognised competencies in heart valve disease6 7 are not universal in all disciplines caring for patients having non-cardiac surgery. Finally, the evidence base is small. A combination of these factors leads to anxiety over the presence of valve disease although this is often misplaced.
- In this window
- In a new window
Prevalence (%) of moderate or severe valve disease
This article discusses the assessment and perioperative management of patients with heart valve disease including replacement valves.
An approach to valve disease
If emergency life-saving surgery is needed, this should proceed immediately (figure 1).8–11 If severe valve disease is known or suspected from the history or the presence of a significant murmur, additional precautions should be taken in perioperative care (box 1).
An approach to valve disease. …
Footnotes
Contributors JC is the sole author.
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; externally peer reviewed.